-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Kelly Cappio
Kelly is the Manager of Vaccines and Biodefense Policy at BIO. In her role, she advocates for policies, regulations, and legislation that improve public health through immunization and emergency preparedness. Originally from the small town of Culpeper, Virginia, Kelly enjoys traveling to new places and living in big cities. She moved to Washington, D.C. in 2009 to pursue a master’s degree in public health from the George Washington University and graduated in May 2011. In her spare time, she loves to read, play tennis, horseback ride, and most of all, spend time with her husband, Matt, and 7-lb poodle, Maeby.
Latest Posts
Vaccines Beyond 2012
Each year, approximately 1.7 million children die from a vaccine-preventable disease, and the vast majority of these deaths occur in developing countries. This BIO 2012 session, moderated by Peg Willingham of the United Nations Foundation, addressed various ways industry can help increase access to life-saving vaccines for children and adults in resource-poor countries. The thoughts of a few of the speakers on the panel for this session are summarized below. The panelists suggested that for Read More >
Implementing the WHO PIP Framework – Industry’s Role & Outlook
In May 2011, the World Health Organization (WHO) adopted the Pandemic Influenza Preparedness (PIP) Framework after nearly five years of contentious negotiations. As noted by Anne Huvos, WHO Secretariat, the two objectives of the PIP Framework are: (1) to improve sharing of influenza viruses with human pandemic potential; and (2) to achieve more predictable, efficient, and equitable access to benefits, such as vaccines and antiviral medicines, during future pandemics. The subject of a session at Read More >
National Infant Immunization Week, April 21-28
Routine immunization of one birth cohort (i.e. people born in a particular year) during childhood prevents about 20 million cases of disease and 42,000 deaths in the U.S. These statistics are staggering, especially when we consider how far vaccinology and preventive medicine have come in such a short time period. Today, vaccines help protect children against 14 diseases before the age of two. Many diseases that parents once feared have been long forgotten. In the Read More >
As Vaccine Exemptions Rise, Risk of Outbreaks Intensifies
Generally, we think of vaccines as protecting the vaccinated. We often forget that vaccines, when administered to enough people, protect those in the community who cannot be vaccinated due to certain health conditions, who are too young to be vaccinated, or who experience vaccine failure. This “herd immunity,” as it’s called, is analogous to the concept of ‘safety in numbers’ and is critical to outbreak prevention. However, as reported by Valerie Bauerlein and Betsy McKay Read More >
World Pneumonia Day: November 12
November 12 marks World Pneumonia Day, a campaign to educate the public about this disease and to advocate for global action to treat and prevent it. Pneumonia is the leading cause of death globally for children under the age of 5, claiming the lives of more than 1.5 million children annually. Pneumonia is also largely a vaccine-preventable disease. Since the introduction of pneumococcal vaccines in the U.S. in 2000, morbidity and mortality from pneumonia have Read More >
